| Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y(12) Receptor Inhibitor Treatment in Percutaneous Coronary Intervention |
73 |
| A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism The OPTALYSE PE Trial |
46 |
| Outcomes After Current Transcatheter Tricuspid Valve Intervention Mid-Term Results From the International TriValve Registry |
46 |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention |
46 |
| The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low Medium and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers The 3M TAVR Study |
42 |
| Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement Concept to First-in-Human |
40 |
| The BASILICA Trial Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction |
39 |
| A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism The FLARE Study |
38 |
| Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement |
37 |
| Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes Insights From the TVT Registry |
33 |
| Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap |
31 |
| The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention Update From the PROGRESS CTO Registry |
30 |
| 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation Results From the TriValve Registry |
29 |
| Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement |
28 |
| Transcatheter Valve Repair for Patients With Mitral Regurgitation 30-Day Results of the CLASP Study |
26 |
| Carotid Stenting With Antithrombotic Agents and Intracranial Thrombectomy Leads to the Highest Recanalization Rate in Patients With Acute Stroke With Tandem Lesions |
26 |
| Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement |
26 |
| Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report |
24 |
| Management of Coronary Artery Aneurysms |
23 |
| Influence of Microcirculatory Dysfunction on Angiography-Based Functional Assessment of Coronary Stenoses |
22 |
| Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement The German Aortic Valve Registry |
22 |
| Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement From Computed Tomography to BASILICA |
22 |
| Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention The DEFINE PCI Study |
22 |
| Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease The RESTORE SVD China Randomized Trial |
21 |
| Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction The REVELATION Randomized Trial |
21 |
| Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement |
21 |
| Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection A Population-Based Analysis |
20 |
| Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures |
20 |
| Early Versus Standard Discharge After Transcatheter Aortic Valve Replacement A Systematic Review and Meta-Analysis |
20 |
| The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement Findings From an International Registry |
19 |
| Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement Insights From the STS/ACC TVT Registry |
19 |
| Anatomic Basis and Physiological Rationale of Distal Radial Artery Access for Percutaneous Coronary and Endovascular Procedures |
19 |
| Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction |
19 |
| Update in the Percutaneous Management of Coronary Chronic Total Occlusions |
19 |
| Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves |
19 |
| The SAVI-TF Registry 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 000 Patients |
18 |
| Predictors of Advanced Conduction Disturbances Requiring a Late (>= 48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement |
18 |
| Management of Calcific Coronary Artery Lesions Is it Time to Change Our Interventional Therapeutic Approach? |
18 |
| Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease Meta-Analysis and Meta-Regression of Randomized Trials |
18 |
| Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes |
18 |
| Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention Outcomes From the Pan-London PCI Cohort |
18 |
| Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention |
18 |
| TAVR in Low-Risk Patients 1-Year Results From the LRT Trial |
18 |
| Improvement of Risk Prediction After Transcatheter Aortic Valve Replacement by Combining Frailty With Conventional Risk Scores |
17 |
| Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair |
17 |
| Coronary Embolus An Underappreciated Cause of Acute Coronary Syndromes |
17 |
| Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain 2-Year Results From the IN.PACT Global Study |
17 |
| Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent 5-Year Outcomes of the Randomized BIOFLOW-II Trial |
17 |
| Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli Insights From the CHOICE Trial and the CHOICE-Extend Registry |
17 |
| The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement Matched Comparison of the Evolut PRO and Evolut R |
17 |
